Fig. 2From: A clinical study on bone defect reconstruction and functional recovery in benign bone tumors of the lower extremity, treated by bone marrow mesenchymal stem cell rapid screening–enrichment–composite systemEvaluation of the osteogenic effects of mesenchymal stem cell (MSC)/TCP bioactive scaffolds in vivo (n = 5). a The control group showed less osteogenesis. b However, there were more new bone components in the experimental group, which distributed in a reticular manner. c The osteogenic effects in the experimental group were statistically higher than the control group (P < 0.05)Back to article page